The purpose of this research study is to learn more about variants in the TP53 gene both associated with Li-Fraumeni Syndrome (LFS), a hereditary cancer risk c…

Li-Fraumeni SyndromeTP53 Gene MutationHereditary Cancer Syndrome+2 more

~Estimated

~$10 – $1,125

Dana-Farber Cancer InstituteNCT04541654

Phase 1

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated/Deleted AML Patients

Axatilimab combined with Decitabine/Venetoclax for the treatment of TP53-mutated/deleted AML patients

Acute Myeloid LeukemiaTP53 Gene Mutation

~Estimated

~$10 – $6,250

Northside Hospital, Inc.NCT07511062